Glenmark Life Sciences: Board Meeting Intimation for Inter Alia To Consider And Approve The Unaudited Financial Results Of The Company For The Second Quarter And Half Year Ended 30Th September 2024.

Glenmark Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/10/2024 inter alia to consider and approve the Unaudited Financial Results of the Company for the second quarter and half year ended 30th September 2024.